Effect of Lutein, Zeaxanthin, and Meso-Zeaxanthin Supplementation on Skin Carotenoid Concentration: A Six-Month, Placebo-Controlled Crossover Study

Part of paid clinical trials in Kansas City, Missouri.

Sponsor
Insight Eyecare Specialties, Inc. dba Vision Source Eyecare,
Study ID
NCT06965426
Status
Recruiting
Apply to this trial

Conditions

  • Macular Degenerative Disease

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Lutein, Zeaxanthin, and Meso-Zeaxanthin Supplementation — OTHER
    Lutein, Zeaxanthin, and Meso-Zeaxanthin Supplementation

Study Details

To compare skin carotenoid scores over 12 weeks of individuals randomized to placebo or MacuHealth and comparing that to a 12 week crossover evaluation.

Key Dates

Start date
Jun 1, 2025
Status verified
Sep 2025
Primary completion
Jan 15, 2026
Completion
Dec 1, 2026

Study Design

Enrollment
60 participants (estimated)
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION

Arms

  • Active Comparator: MacuHealth Supplementation
    Lutein, Zeaxanthin, and Meso-Zeaxanthin Supplementation
  • Placebo Comparator: Placebo
    Placebo

Primary Outcome Measure

Carotenoid concentration [ Time Frame: 6 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Vision SourceKansas CityMissouri64111
Crystal Remington Remington, OD
[email protected]
816-531-9100
Ryan Powell Powell, OD
[email protected]
8164764017

Find similar trials in Kansas City, MO

By research site
Vision Source· Kansas City, MO

Related Studies